ACTON, Mass. --(BUSINESS WIRE)--Sep. 22, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the third quarter of 2022 on November
ACTON, Mass. --(BUSINESS WIRE)--Sep. 20, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced it has received CE marking under the European Medical Device Regulation for its
Omnipod 5 is the first tubeless AID System cleared in the U.S. for preschool children ACTON, Mass. --(BUSINESS WIRE)--Aug. 22, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today
ACTON, Mass. --(BUSINESS WIRE)--Aug. 5, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at four upcoming investor conferences (all Eastern Time): The
Recently Launched U.S. Full Market Release for Omnipod ® 5 - Now Available through Retail Pharmacies ACTON, Mass. --(BUSINESS WIRE)--Aug. 4, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of
Omnipod 5 is Now Fully Available through Retail Pharmacy Channels ACTON, Mass. --(BUSINESS WIRE)--Aug. 1, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its Omnipod ® 5
ACTON, Mass. --(BUSINESS WIRE)--Jun. 30, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the second quarter of 2022 on August
Insulet Presents Pivotal Extension Data for Preschool Children and Other Omnipod® 5 System Clinical Research at American Diabetes Association 82 nd Scientific Sessions ACTON, Mass. --(BUSINESS WIRE)--Jun. 3, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in
ACTON, Mass. --(BUSINESS WIRE)--Jun. 2, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at the William Blair & Company 42 nd Annual Growth Stock Conference
ACTON, Mass. --(BUSINESS WIRE)--Jun. 1, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host a groundbreaking ceremony for its new manufacturing facility in Malaysia , further
Director Jim Hollingshead to Succeed Shacey Petrovic as President and CEO, Effective June 1, 2022 Petrovic and Hollingshead to Continue as Members of Insulet’s Board of Directors ACTON, Mass. --(BUSINESS WIRE)--May 5, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global
ACTON, Mass. --(BUSINESS WIRE)--May 5, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended March 31, 2022 .
ACTON, Mass. --(BUSINESS WIRE)--May 2, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the release of its 2021 Sustainability Report.
ACTON, Mass. --(BUSINESS WIRE)--Apr. 27, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented new Omnipod® 5 Automated Insulin Delivery (AID) System study results in type 2
ACTON, Mass. --(BUSINESS WIRE)--Apr. 7, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the first quarter of 2022 on May 5,
